home / stock / innt / innt news

INNT News and Press, Innovate Biopharmaceuticals Inc. From 03/18/19

Stock Information
Company Name: Innovate Biopharmaceuticals Inc.
Stock Symbol: INNT
Market: NASDAQ
Website: innovatebiopharma.com
Menu
INNT INNT Quote INNT Short INNT News INNT Articles INNT Message Board
Get INNT Alerts

News, Short Squeeze, Breakout and More Instantly...
INNT - Healthcare names top midday movers

Gainers:  Dermira (NASDAQ: DERM ) +85% . PhaseBio Pharmaceuticals (NASDAQ: PHAS ) +48% . Atossa Genetics (NASDAQ: ATOS ) +35% . American Midstream Partners (NYSE: AMID ) +28% . Aclaris Therapeutics (NASDAQ: ACRS ) +21% . Innovate Biopharmaceuticals (NASDAQ: INNT ) +20% . Profess...
INNT - Innovate Biopharmaceuticals Announces Entry Into Securities Purchase Agreement to Fund Initiation of the First Phase 3 Celiac Disease Clinical Trial

RALEIGH, N.C., March 18, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate” or the “Company”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel autoimmune and inflammation therapeutics, announced that on Ma...

INNT - Innovate Biopharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 18, 2019

RALEIGH, N.C., March 13, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel autoimmune and inflammation therapeutics, announced that it intends to host an audio webcast ...

INNT - Innovate Biopharmaceuticals Announces Presentation at Cowen's 39th Annual Health Care Conference in Boston

RALEIGH, N.C., March 06, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel autoimmune and inflammation therapeutics, announced company executives intend to present at Cowen’s 39th Annual...
INNT - Innovate Biopharmaceuticals (INNT) Presnts At Conference Call to Provide Corporate and Operational Updates - Slideshow

The following slide deck was published by Innovate Biopharmaceuticals, Inc. in conjunction with this Read more ...

INNT - Innovate Biopharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 14, 2019

RALEIGH, N.C., March 01, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel autoimmune and inflammation therapeutics, announced that it intends to host an audio webcast ...

INNT - Innovate Biopharmaceuticals Schedules Conference Call to Provide Corporate and Operational Progress Updates

RALEIGH, N.C., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel autoimmune and inflammation therapeutics, announced company executives intend to host a confer...
INNT - Innovate Biopharmaceuticals Announces Acceptance of Three Abstracts Focusing on the Molecular Biology and Pharmacology of Larazotide for the 2019 Digestive Disease Week Conference

RALEIGH, N.C., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc.  (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases, announced that three abstracts were accepted for poster prese...

INNT - Innovate Biopharmaceuticals Announces a New Chief Executive Officer and Chief Medical Officer

 RALEIGH, N.C., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals , Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases, announced the departure of the Chief Executive Officer and mem...

INNT - Innovate Biopharmaceuticals Announces Presentation at BIO CEO & Investor Conference

RALEIGH, N.C., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT) a clinical stage biotechnology company focused on developing novel autoimmune and inflammation therapeutics, announced its intent to present at the BIO CEO & Investor Conference tak...
Previous 10 Next 10